Androgen Deprivation Therapy and Orteronel or Bicalutamide in Treating Patients with Newly Diagnosed Metastatic Prostate Cancer

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeAgeTrial IDs
Phase IIITreatment18 and overS1216
NCI-2012-02876, SWOG-S1216, NCT01809691

Trial Description

Summary

This randomized phase III trial studies androgen deprivation therapy and orteronel to see how well it works compared to androgen deprivation therapy and bicalutamide in treating patients with newly diagnosed prostate cancer that has spread to other places in the body. Androgen deprivation therapy suppresses or blocks the production or action of male hormones. Androgens can cause the growth of prostate cancer cells. Drugs, such as orteronel and bicalutamide, may lessen the amount of androgens made by the body. It is not yet known whether giving androgen deprivation therapy with orteronel or bicalutamide is more effective in treating prostate cancer.

Further Study Information

PRIMARY OBJECTIVES:

I. To compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) (luteinizing hormone releasing hormone analogue [LHRHa] or orchiectomy) + TAK-700 (orteronel) versus ADT (LHRHa or orchiectomy) + bicalutamide.

SECONDARY OBJECTIVES:

I. To compare progression free survival between the two arms.

II. To compare distributions of prostate specific antigen (PSA) response (< 0.2 vs. 0.2-4.0 vs. > 4.0 ng/ml) between the treatment arms at 7 months post-randomization.

III. To compare the qualitative and quantitative adverse events from each treatment arm.

IV. To characterize the long-term survival in both treatment arms after 10 years of follow-up.

TERTIARY OBJECTIVES:

I. To validate the prognostic and predictive value of markers of bone turnover in newly-diagnosed metastatic hormone sensitive prostate cancer patients treated with TAK-700.

II. To bank plasma/whole blood and tissue specimens for future use.

III. To evaluate genomic variants and gene expression of androgen pathway genes and their correlation with response to therapy (ADT + TAK-700 vs. ADT + bicalutamide).

OUTLINE: Patients who are not surgically castrated are randomized to 1 of 2 treatment arms. Patients who are surgically castrated receive only orteronel (Arm I) or bicalutamide (Arm II).

ARM I: Patients receive goserelin acetate or leuprolide acetate subcutaneously (SC) or intramuscularly (IM) once every 3 months and orteronel orally (PO) twice daily (BID).

ARM II: Patients receive goserelin acetate or leuprolide acetate as in Arm I and bicalutamide PO once daily (QD).

In both arms, treatment continues in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up annually for up to 10 years.

Eligibility Criteria

Inclusion Criteria:

Patients must not have New York Heart Association class III or IV heart failure at the time of screening; patients must not have any thromboembolic event, unstable angina pectoris, myocardial infarction, or serious uncontrolled cardiac arrhythmia within 6 months prior to registration (Note: Patients with congenital long AT syndrome, congestive heart failure, frequent electrolyte abnormalities, and patients taking drugs known to prolong the QT interval may be at increased risk)

Patients must have a left ventricular ejection fraction (LVEF) > 50% by echocardiogram or multiple gated acquisition (MUGA) scan within 42 days prior to registration

Patient must have a corrected QT interval (QTc) interval < 461 msec on the 12 lead electrocardiogram (ECG) within 42 days prior to registration

A dual-energy X-ray absorptiometry (DEXA) scan must be obtained within 2 years prior to registration

Patients must have a PSA >= 2 ng/mL obtained within 90 days prior to registration

Patients must have a complete physical examination and medical history within 28 days prior to registration

In the late induction group, patients must have had no more than 30 days of prior castration (medical or surgical) for metastatic prostate cancer prior to registration; the start date of medical castration is considered the day the patient first received an injection of a LHRH agonist/antagonist (or orchiectomy), not an oral antiandrogen

If the method of castration was luteinizing hormone releasing hormone (LHRH) agonists (i.e., leuprolide or goserelin), the patient must be willing to continue the use of LHRH agonist and add bicalutamide or TAK-700 (according to randomization) during protocol treatment

If the patient was on an antiandrogen (e.g. bicalutamide, flutamide), the patient must be willing to switch over to bicalutamide or TAK-700 (according to randomization); no washout is required

If the method of castration was LHRH antagonists (i.e. Degarelix), the patient must be willing to switch to an LHRH agonist during protocol treatment

Patient must have no plans to receive any other experimental therapy while on the protocol treatment; previous experimental therapy must have been completed at least 28 days prior to registration

Patient may have received or plan to receive concurrent bone targeting agents that do not have an effect on PSA (e.g. denosumab or bisphosphonate)

Patients may have received prior surgery; for all major surgeries, at least 14 days must have elapsed since completion and patient must have recovered from all major side effects of surgery per investigator’s assessment

Patients must not have received any prior cytotoxic chemotherapy for metastatic prostate cancer; prior cytotoxic chemotherapy with curative intent in the neoadjuvant or adjuvant setting is allowed; at least 2 years must have elapsed since completion of cytotoxic chemotherapy in the neoadjuvant and/or adjuvant setting

Patients must not have received prior and/or must not have any plans for receiving concomitant therapy with ketoconazole, aminoglutethimide, or abiraterone acetate, or enzalutamide (MDV3100); concurrent megestrol for hot flashes is allowed

Patients may have received prior androgen deprivation therapy (ADT) - neoadjuvant and/or adjuvant setting only, but it must not have lasted for more than 36 months; single or combination therapy allowed; at least 6 months must have elapsed since completion of androgen deprivation therapy in the neoadjuvant and/or adjuvant setting, and serum testosterone must be > 50 ng/mL (non-castrate levels) within 28 days prior to registration for early induction patients; Note: serum testosterone assessment is required for eligibility for only those with prior treatment with ADT

Patients with known brain metastases are not eligible; brain imaging studies are not required for eligibility if the patient has no neurologic signs or symptoms suggestive of brain metastasis; but, if brain imaging studies are performed, they must be negative for disease

Patients who will not have an LHRH injection until after randomization (early induction group) must have radiographic assessments of all disease including bone scan (or positron emission tomography [PET] scan) within 42 days prior to registration; patients who have started androgen deprivation therapy (LHRH agonist/antagonist or orchiectomy) prior to registration (late induction group) must have radiographic assessments including bone scan (or PET scan) within 42 days prior to first LHRH injection (if scans have not been obtained prior to LHRH agonist/antagonist or orchiectomy they must be done within 42 days prior to registration); all disease must be assessed and documented on the Baseline Tumor Assessment Form

All patients must have a histologically or cytologically proven diagnosis of adenocarcinoma of the prostate; all patients must have metastatic disease as evidenced by soft tissue and/or bony metastases prior to initiation of androgen deprivation therapy

Disease Related Criteria:

There are two patient populations eligible for the study: those who have not started any therapy with LHRH agonist or antagonist (or orchiectomy) (Early Induction Group) and those who have already started therapy with LHRH agonist or antagonist (or orchiectomy) within the 30 days prior to registration (Late Induction Group); patients must be registered within 30 days of first injection of the LHRH agonist or antagonist (or orchiectomy)

Patients must not have known gastrointestinal (GI) disease or GI procedure that could interfere with the GI absorption or tolerance of TAK-700, including difficulty swallowing oral medications

Patient must not be known to have hypersensitivity to TAK-700, to TAK-700 metabolites, to bicalutamide, or to LHRH agonist

Patients with a known history of primary and secondary adrenal insufficiency are not eligible

Patient must not be known to have human immunodeficiency virus (HIV) infection, active chronic hepatitis B or C, life-threatening illness unrelated to cancer, or any serious medical or psychiatric illness that could, in the investigator’s opinion, potentially interfere with participation in this study; patients will be tested for hepatitis B or C or HIV infection during screening if they are considered by the investigator to be at higher risk for these infections and have not been previously tested

Platelets >= 100,000/mcL; these results must be obtained within 28 days prior to registration

Hemoglobin >= 9 g/dL; these results must be obtained within 28 days prior to registration

Absolute neutrophil count (ANC) >= 1,500/mcL; these results must be obtained within 28 days prior to registration

Leukocytes >= 3,000/mcL; these results must be obtained within 28 days prior to registration

Calculated creatinine clearance >= 40 mL/min using a serum creatinine obtained within 28 days prior to registration

Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) and serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 3 x institutional ULN, or =< 5 x institutional ULN if liver metastases are present; these results must be obtained within 28 days prior to registration

Bilirubin =< 2 x institutional upper limit of normal (ULN); these results must be obtained within 28 days prior to registration

Patients must have blood pressure measured within 14 days prior to registration; patients must not have uncontrolled hypertension (defined as blood pressure > 160 mmHg systolic and > 90 mmHg diastolic at 2 separate measurements no more than 60 minutes apart) despite appropriate medical therapy; Note: patients may be rescreened after adjustments of antihypertensive medications

Clinical/Laboratory Criteria:

Prior Therapy Criteria:

Patients who are deemed to have high-risk or extensive metastatic, hormone sensitive prostate cancer (mHSPC) per “clinical judgment” of the treating physician are eligible for enrollment if they are unsuitable candidates for docetaxel or if they have declined docetaxel therapy

As a part of the OPEN registration process, the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system

Patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Voluntary written informed consent must be obtained before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care

Regulatory Criteria:

Patients must be offered the opportunity to participate in specimen banking for future use to include translational medicine studies

Specimen Submission Criteria:

Men of reproductive potential and those who are surgically sterilized (i.e., post-vasectomy) must agree to practice effective barrier contraception or agree to abstain from intercourse while receiving treatment on this study and for at least 4 months after protocol treatment ends

No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease-free for 5 years

Patients must have a Zubrod performance status of 0 - 2; Zubrod performance status 3 will be allowed if from bone pain only

Trial Contact Information

Trial Lead Organizations / Sponsors / Collaborators

SWOG

  • National Cancer Institute
Neeraj Agarwal, Principal Investigator

Trial Sites

U.S.A.

Alabama
Birmingham

Veterans Administration Medical Center - Birmingham

Guru P. Sonpavde
Ph: 205-934-0309

Guru P. Sonpavde
Principal Investigator

Arizona
Tucson

The University of Arizona Cancer Center-North Campus

Parminder Singh
Ph: 520-626-9008

Parminder Singh
Principal Investigator

The University of Arizona Cancer Center-Orange Grove Campus

Parminder Singh
Ph: 520-626-9008

Parminder Singh
Principal Investigator

The University of Arizona Medical Center-University Campus

Parminder Singh
Ph: 520-626-9008

Parminder Singh
Principal Investigator

Arkansas
Little Rock

Veteran's Administration Medical Center

Rangaswamy Govindarajan
Ph: 501-686-8274

Rangaswamy Govindarajan
Principal Investigator

California
Antioch

Kaiser Permanente-Deer Valley Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Auburn

Sutter Auburn Faith Hospital

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Berkeley

Alta Bates Summit Medical Center-Herrick Campus

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Burlingame

Mills - Peninsula Hospitals

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Davis

Sutter Davis Hospital

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Duarte

City of Hope Comprehensive Cancer Center

Przemyslaw W. Twardowski
Ph: 800-826-4673
Email: becomingapatient@coh.org

Przemyslaw W. Twardowski
Principal Investigator

Fremont

Kaiser Permanente, Fremont

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Fresno

Kaiser Permanente

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

La Jolla

UC San Diego Moores Cancer Center

Frederick Edward Millard
Ph: 858-822-5354
Email: cancercto@ucsd.edu

Frederick Edward Millard
Principal Investigator

Loma Linda

Loma Linda University Medical Center

Chien-Shing (C.S.) Chen
Ph: 909-558-3375

Chien-Shing (C.S.) Chen
Principal Investigator

Veterans Affairs Loma Linda Healthcare System

Daljeet Bhatia Bansal
Ph: 800-741-8387

Daljeet Bhatia Bansal
Principal Investigator

Los Angeles

Los Angeles County-USC Medical Center

David Ian Quinn
Ph: 323-865-0451

David Ian Quinn
Principal Investigator

USC / Norris Comprehensive Cancer Center

David Ian Quinn
Ph: 323-865-0451

David Ian Quinn
Principal Investigator

Marysville

Fremont - Rideout Cancer Center

Primo Nery Lara
Ph: 916-734-3089

Primo Nery Lara
Principal Investigator

Merced

Mercy UC Davis Cancer Center

Prasad Pillai
Ph: 916-734-3089

Prasad Pillai
Principal Investigator

Modesto

Kaiser Permanente-Modesto

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Mountain View

Palo Alto Medical Foundation-Camino Division

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Palo Alto Medical Foundation-Gynecologic Oncology

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Novato

Sutter Cancer Research Consortium

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Oakland

Kaiser Permanente-Oakland

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Orange

UC Irvine Health/Chao Family Comprehensive Cancer Center

John Paul Fruehauf
Ph: 877-827-8839
Email: ucstudy@uci.edu

John Paul Fruehauf
Principal Investigator

Palo Alto

Palo Alto Medical Foundation Health Care

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Paradise

Feather River Cancer Center

Sam Mazj
Ph: 530-876-7995
Email: haleew@ah.org

Sam Mazj
Principal Investigator

Pasadena

Keck Medical Center of USC Pasadena

David Ian Quinn
Ph: 323-865-0451

David Ian Quinn
Principal Investigator

Pismo Beach

Palchak David MD

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Redwood City

Kaiser Permanente-Redwood City

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Richmond

Kaiser Permanente-Richmond

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Roseville

Kaiser Permanente-Roseville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Roseville Medical Center

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Sacramento

Kaiser Permanente - Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Kaiser Permanente-South Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter General Hospital

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

University of California Davis Comprehensive Cancer Center

Primo Nery Lara
Ph: 916-734-3089

Primo Nery Lara
Principal Investigator

San Francisco

California Pacific Medical Center-Pacific Campus

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Kaiser Permanente-San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

UCSF Medical Center-Mission Bay

Terence Ware Friedlander
Ph: 877-827-3222

Terence Ware Friedlander
Principal Investigator

UCSF Medical Center-Mount Zion

Terence Ware Friedlander
Ph: 877-827-3222

Terence Ware Friedlander
Principal Investigator

San Jose

Kaiser Permanente-Santa Teresa-San Jose

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Leandro

Kaiser Permanente San Leandro

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Rafael

Kaiser Permanente-San Rafael

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Clara

Kaiser Permanente Medical Center - Santa Clara

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Cruz

Palo Alto Medical Foundation-Santa Cruz

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Santa Rosa

Kaiser Permanente-Santa Rosa

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Pacific Medical Foundation

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

South San Francisco

Kaiser Permanente-South San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Stockton

Kaiser Permanente-Stockton

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sunnyvale

Palo Atlo Medical Foundation-Sunnyvale

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Truckee

Tahoe Forest Cancer Center

Primo Nery Lara
Ph: 916-734-3089

Primo Nery Lara
Principal Investigator

Vacaville

Kaiser Permanente Medical Center-Vacaville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Vallejo

Kaiser Permanente-Vallejo

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Solano Medical Center/Cancer Center

Ari David Baron
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Ari David Baron
Principal Investigator

Walnut Creek

Kaiser Permanente-Walnut Creek

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Colorado
Aurora

Rocky Mountain Cancer Centers-Aurora

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

The Medical Center of Aurora

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

University of Colorado Cancer Center - Anschutz Cancer Pavilion

Paul Daniel Maroni
Ph: 720-848-0650

Paul Daniel Maroni
Principal Investigator

Boulder

Boulder Community Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Boulder

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Colorado Springs

Penrose-Saint Francis Healthcare

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Penrose

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Denver

Colorado Blood Cancer Institute

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Colorado Cancer Research Program CCOP

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Exempla Saint Joseph Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Porter Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Presbyterian - Saint Lukes Medical Center - Health One

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Midtown

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Rose

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rose Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Durango

Mercy Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Southwest Oncology PC

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Englewood

Comprehensive Cancer Care and Research Institute of Colorado LLC

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Swedish Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Golden

Mountain Blue Cancer Care Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Greeley

North Colorado Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Greenwood Village

Rocky Mountain Cancer Centers-Greenwood Village

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Lakewood

Rocky Mountain Cancer Centers-Lakewood

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Saint Anthony Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Littleton

Littleton Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Littleton

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Lone Tree

Rocky Mountain Cancer Centers-Sky Ridge

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Sky Ridge Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Longmont

Longmont United Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Longmont

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Loveland

McKee Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Parker

Parker Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Parker

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Pueblo

Rocky Mountain Cancer Centers - Pueblo

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Saint Mary Corwin Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Thornton

Rocky Mountain Cancer Centers-Thornton

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Wheat Ridge

Exempla Lutheran Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Connecticut
Greenwich

Greenwich Hospital

Daniel P. Petrylak
Ph: 203-785-5702

Daniel P. Petrylak
Principal Investigator

New Haven

Yale University

Daniel P. Petrylak
Ph: 203-785-5702

Daniel P. Petrylak
Principal Investigator

Norwich

Eastern Connecticut Hematology and Oncology Associates

Dennis E. Slater
Ph: 860-886-8362

Dennis E. Slater
Principal Investigator

Delaware
Lewes

Beebe Medical Center

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Newark

Christiana Care Health System-Christiana Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Seaford

Nanticoke Memorial Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

District of Columbia
Washington

George Washington University Medical Center

Jeanny Bautista Aragon-Ching
Ph: 202-741-2981

Jeanny Bautista Aragon-Ching
Principal Investigator

MedStar Georgetown University Hospital

Nancy Ann Dawson
Ph: 202-444-0381

Nancy Ann Dawson
Principal Investigator

Sibley Memorial Hospital

Channing J. Paller
Ph: 410-955-8804
Email: jhcccro@jhmi.edu

Channing J. Paller
Principal Investigator

Veterans Affairs Medical Center -Washington DC

Anthony Gerard S. Arcenas
Ph: 877-328-2621

Anthony Gerard S. Arcenas
Principal Investigator

Washington Hospital Center

Nancy Ann Dawson
Ph: 202-444-0381

Nancy Ann Dawson
Principal Investigator

Florida
Fort Lauderdale

Broward Health Medical Center

Archana Maini
Ph: 954-355-5346

Archana Maini
Principal Investigator

Lakeland

Lakeland Regional Cancer Center

Gameel Byron Hodge
Ph: 863-904-1900

Gameel Byron Hodge
Principal Investigator

Orlando

Florida Hospital Orlando

Lee M. Zehngebot
Ph: 407-303-5623

Lee M. Zehngebot
Principal Investigator

UF Cancer Center at Orlando Health

Daniel Landau
Ph: 321-841-7246
Email: CancerClinicalTrials@orlandohealth.com

Daniel Landau
Principal Investigator

Georgia
Columbus

John B Amos Cancer Center

Andrew W. Pippas
Ph: 706-660-6404

Andrew W. Pippas
Principal Investigator

Decatur

Atlanta VA Medical Center

Wayne Bernard Harris
Ph: 404-778-1868

Wayne Bernard Harris
Principal Investigator

Gainesville

Northeast Georgia Medical Center

Charles H. Nash
Ph: 770-219-8800
Email: cancerpatient.navigator@nghs.com

Charles H. Nash
Principal Investigator

Savannah

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

Mark Alexander Taylor
Ph: 912-350-8568

Mark Alexander Taylor
Principal Investigator

Hawaii
Honolulu

Kaiser Permanente Moanalua Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Tripler Army Medical Center

Jeffrey L. Berenberg
Ph: 808-586-2979

Jeffrey L. Berenberg
Principal Investigator

Idaho
Boise

Saint Alphonsus Cancer Care Center-Boise

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Coeur D'Alene

Kootenai Medical Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Post Falls

Kootenai Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Sandpoint

Kootenai Cancer

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Illinois
Bloomington

Illinois CancerCare-Bloomington

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Saint Joseph Medical Center

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Canton

Illinois CancerCare-Canton

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Carthage

Illinois CancerCare-Carthage

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Chicago

Mount Sinai Hospital Medical Center

Pam G. Khosla
Ph: 773-257-5960
Email: suhi@sinai.org

Pam G. Khosla
Principal Investigator

Saint Joseph Hospital

Ira Anton Oliff
Ph: 773-665-3109

Ira Anton Oliff
Principal Investigator

University of Chicago Comprehensive Cancer Center

Chadi Nabhan
Ph: 773-834-7424

Chadi Nabhan
Principal Investigator

University of Illinois

David J. Peace
Ph: 312-355-3046

David J. Peace
Principal Investigator

Weiss Memorial Hospital

Stuart A. Krauss
Ph: 773-564-5044

Stuart A. Krauss
Principal Investigator

Decatur

Central Illinois CCOP

Neeraj Agarwal
Ph: 801-587-4765
Email: neeraj.agarwal@hci.utah.edu

Neeraj Agarwal
Principal Investigator

Decatur Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Effingham

Crossroads Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Eureka

Illinois CancerCare-Eureka

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Evanston

NorthShore University HealthSystem-Evanston Hospital

Daniel H. Shevrin
Ph: 847-570-2109

Daniel H. Shevrin
Principal Investigator

Galesburg

Illinois CancerCare Galesburg

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Illinois CancerCare-Galesburg Cottage Plaza Office

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Glenview

NorthShore University HealthSystem-Glenbrook Hospital

Daniel H. Shevrin
Ph: 847-570-2109

Daniel H. Shevrin
Principal Investigator

Highland Park

NorthShore University HealthSystem-Highland Park Hospital

Daniel H. Shevrin
Ph: 847-570-2109

Daniel H. Shevrin
Principal Investigator

Hines

Hines Veterans Administration Hospital

Elizabeth Henry
Ph: 708-226-4357

Elizabeth Henry
Principal Investigator

Joliet

Joliet Oncology-Hematology Associates Limited

Kulumani M. Sivarajan
Ph: 815-730-3098
Email: maureenc@jolietoncology.com

Kulumani M. Sivarajan
Principal Investigator

Kankakee

Presence Saint Mary's Hospital

Silviya V. Velinova
Ph: 815-937-8780

Silviya V. Velinova
Principal Investigator

Kewanee

Illinois CancerCare-Kewanee Clinic

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Macomb

Illinois CancerCare-Macomb

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Maywood

Loyola University Medical Center

Ellen R. Gaynor
Ph: 708-226-4357

Ellen R. Gaynor
Principal Investigator

Moline

Trinity Medical Center

David Martens Spector
Ph: 309-779-4200

David Martens Spector
Principal Investigator

Ottawa

Illinois CancerCare-Ottawa Clinic

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Pekin

Illinois CancerCare-Pekin

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Pekin Cancer Treatment Center

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Peoria

Illinois CancerCare-Peoria

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Methodist Medical Center of Illinois

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

OSF Saint Francis Medical Center

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Peru

Illinois CancerCare-Peru

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Princeton

Illinois CancerCare-Princeton

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

River Forest

West Suburban Medical Center

Stuart A. Krauss
Ph: 773-564-5044

Stuart A. Krauss
Principal Investigator

Rockford

SwedishAmerican Regional Cancer Center/ACT

Harvey E. Einhorn
Ph: 779-696-9400
Email: cancercare@swedishamerican.org

Harvey E. Einhorn
Principal Investigator

Springfield

Memorial Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Urbana

Carle Cancer Center

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Warrenville

Cadence Cancer Center in Warrenville

Robert Michael Eisner
Ph: 630-352-5300

Robert Michael Eisner
Principal Investigator

Indiana
Bloomington

IU Health Bloomington

Jeffrey Paul Allerton
Ph: 812-353-2831

Jeffrey Paul Allerton
Principal Investigator

Mishawaka

Memorial Regional Cancer Center Day Road

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

South Bend

Memorial Hospital of South Bend

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Valparaiso

Porter Memorial Hospital

Ellen R. Gaynor
Ph: 708-226-4357

Ellen R. Gaynor
Principal Investigator

Iowa
Ames

McFarland Clinic PC-William R Bliss Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Clive

Medical Oncology and Hematology Associates-West Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Council Bluffs

Alegent Health Mercy Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Davenport

Genesis Medical Center - East Campus

George Kovach
Ph: 800-446-6088
Email: werners@genesishealth.com

George Kovach
Principal Investigator

Des Moines

Medical Oncology and Hematology Associates-Laurel

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Iowa City

Iowa City VA Healthcare System

Daniel Alberto Vaena
Ph: 800-237-1225

Daniel Alberto Vaena
Principal Investigator

University of Iowa/Holden Comprehensive Cancer Center

Daniel Alberto Vaena
Ph: 800-237-1225

Daniel Alberto Vaena
Principal Investigator

Kansas
Chanute

Cancer Center of Kansas - Chanute

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Dodge City

Cancer Center of Kansas - Dodge City

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

El Dorado

Cancer Center of Kansas - El Dorado

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Fort Scott

Cancer Center of Kansas - Fort Scott

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Garden City

Saint Catherine Hospital

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Great Bend

Saint Rose Ambulatory and Surgery Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Hays

Hays Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Independence

Cancer Center of Kansas-Independence

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Kansas City

Kansas City Cancer Center-West

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

University of Kansas Cancer Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Kingman

Cancer Center of Kansas-Kingman

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Lawrence

Lawrence Memorial Hospital

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Liberal

Cancer Center of Kansas-Liberal

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Newton

Cancer Center of Kansas - Newton

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Olathe

Olathe Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Overland Park

Kansas City Cancer Centers-Southwest

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Parsons

Cancer Center of Kansas - Parsons

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Pratt

Cancer Center of Kansas - Pratt

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Salina

Cancer Center of Kansas - Salina

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Salina Regional Health Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Topeka

Saint Francis Hospital and Medical Center - Topeka

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Topeka VA Hospital

Ace Allen
Ph: 800-525-1483

Ace Allen
Principal Investigator

Wellington

Cancer Center of Kansas - Wellington

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Wichita

Associates In Womens Health

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas - Main Office

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas-Wichita Medical Arts Tower

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Via Christi Regional Medical Center

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Winfield

Cancer Center of Kansas - Winfield

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Kentucky
Lexington

University of Kentucky/Markey Cancer Center

Peng Wang
Ph: 859-257-3379

Peng Wang
Principal Investigator

Louisiana
Baton Rouge

Ochsner Health Center-Summa

Marc R. Matrana
Ph: 888-562-4763

Marc R. Matrana
Principal Investigator

Kenner

Ochsner Medical Center Kenner

Marc R. Matrana
Ph: 888-562-4763

Marc R. Matrana
Principal Investigator

New Orleans

Interim LSU Public Hospital

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Louisiana State University Health Science Center

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Ochsner Medical Center Jefferson

Marc R. Matrana
Ph: 888-562-4763

Marc R. Matrana
Principal Investigator

Shreveport

Louisiana State University Health Sciences Center Shreveport

Donald A. Elmajian
Ph: 318-813-1412

Donald A. Elmajian
Principal Investigator

Maine
Augusta

Harold Alfond Center for Cancer Care

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Rockport

Penobscot Bay Medical Center

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Maryland
Baltimore

Johns Hopkins University/Sidney Kimmel Cancer Center

Channing J. Paller
Ph: 410-955-8804
Email: jhcccro@jhmi.edu

Channing J. Paller
Principal Investigator

Olney

Montgomery General Hospital-Olney

Nancy Ann Dawson
Ph: 202-444-0381

Nancy Ann Dawson
Principal Investigator

Massachusetts
Boston

Boston Medical Center

Gretchen A. Gignac
Ph: 617-638-8265

Gretchen A. Gignac
Principal Investigator

Burlington

Lahey Hospital and Medical Center

Jacob M. Sands
Ph: 781-744-8027

Jacob M. Sands
Principal Investigator

Fall River

Saint Anne's Hospital

John Li-Hsiang Yang
Ph: 508-674-5600

John Li-Hsiang Yang
Principal Investigator

Quincy

Dana Farber Community Cancer Care-Quincy

James R. Everett
Ph: 781-337-9091

James R. Everett
Principal Investigator

Springfield

Baystate Medical Center

Leslie Marion Howard
Ph: 413-794-3565
Email: tamara.wrenn@baystatehealth.org

Leslie Marion Howard
Principal Investigator

Michigan
Adrian

Hickman Cancer Center

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Ann Arbor

Michigan Cancer Research Consortium CCOP

Neeraj Agarwal
Ph: 801-587-4765
Email: neeraj.agarwal@hci.utah.edu

Neeraj Agarwal
Principal Investigator

Saint Joseph Mercy Hospital

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

University of Michigan Comprehensive Cancer Center

Neeraj Agarwal
Ph: 801-587-4765
Email: neeraj.agarwal@hci.utah.edu

Neeraj Agarwal
Principal Investigator

Battle Creek

Bronson Battle Creek

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Detroit

Saint John Hospital and Medical Center

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Escanaba

Green Bay Oncology - Escanaba

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Farmington

Botsford General Hospital

Jason Matthew Hafron
Ph: 248-786-0467
Email: osterhoutd@michiganurology.com

Jason Matthew Hafron
Principal Investigator

Grand Rapids

Spectrum Health at Butterworth Campus

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Iron Mountain

Green Bay Oncology - Iron Mountain

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Kalamazoo

West Michigan Cancer Center

Sunil Nagpal
Ph: 269-373-7458

Sunil Nagpal
Principal Investigator

Lansing

Sparrow Hospital

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Niles

Lakeland Community Hospital

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Pontiac

Saint Joseph Mercy Oakland

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Port Huron

Saint Joseph Mercy Port Huron

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Reed City

Spectrum Health Reed City Hospital

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Royal Oak

William Beaumont Hospital-Royal Oak

Jason Matthew Hafron
Ph: 248-786-0467
Email: osterhoutd@michiganurology.com

Jason Matthew Hafron
Principal Investigator

Saint Joseph

Marie Yeager Cancer Center

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Traverse City

Munson Medical Center

Gilbert D.A. Padula
Ph: 616-685-5225
Email: connie.szczepanek@grcop.org

Gilbert D.A. Padula
Principal Investigator

Troy

William Beaumont Hospital - Troy

Jason Matthew Hafron
Ph: 248-786-0467
Email: osterhoutd@michiganurology.com

Jason Matthew Hafron
Principal Investigator

Warren

Saint John Macomb-Oakland Hospital

Philip J. Stella
Ph: 734-712-4673

Philip J. Stella
Principal Investigator

Minnesota
Bemidji

Sanford Clinic North-Bemidgi

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Burnsville

Fairview Ridges Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Coon Rapids

Mercy Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Duluth

Essentia Health Cancer Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Edina

Fairview-Southdale Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Fergus Falls

Lake Region Healthcare Corporation-Cancer Care

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Maplewood

Minnesota Oncology Hematology PA-Maplewood

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Saint John's Hospital - Healtheast

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Minneapolis

Abbott-Northwestern Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Health Partners Inc

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Hennepin County Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Robbinsdale

North Memorial Medical Health Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Rochester

Mayo Clinic

Manish Kohli
Ph: 507-538-7623

Manish Kohli
Principal Investigator

Saint Cloud

Coborn Cancer Center at Saint Cloud Hospital

Donald James Jurgens
Ph: 877-229-4907
Email: coborncancercenter@centracare.com

Donald James Jurgens
Principal Investigator

Saint Louis Park

Park Nicollet Clinic - Saint Louis Park

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Saint Paul

Regions Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

United Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Shakopee

Saint Francis Regional Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Stillwater

Lakeview Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Mississippi
Jackson

University of Mississippi Medical Center

Barbara S. Craft
Ph: 601-815-6700

Barbara S. Craft
Principal Investigator

Missouri
Cape Girardeau

Saint Francis Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southeast Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Columbia

University of Missouri - Ellis Fischel

Carl Ernest Freter
Ph: 573-882-7440

Carl Ernest Freter
Principal Investigator

Kansas City

Kansas City Cancer Center - South

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Kansas City Cancer Centers - North

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Kansas City Veterans Affairs Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Research Medical Center

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Rakesh Gaur
Principal Investigator

Saint Luke's Hospital of Kansas City

Rakesh Gaur
Ph: 913-948-5588
Email: aroland@kccop.org

Rakesh Gaur
Principal Investigator

Truman Medical Center

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Lee's Summit

Kansas City Cancer Center-Lee's Summit

Peter J. Van Veldhuizen
Ph: 800-525-1483

Peter J. Van Veldhuizen
Principal Investigator

Rolla

Phelps County Regional Medical Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Saint Louis

Barnes-Jewish West County Hospital

Joel Picus
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Joel Picus
Principal Investigator

Mercy Hospital Saint Louis

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Missouri Baptist Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Washington University School of Medicine

Joel Picus
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Joel Picus
Principal Investigator

Saint Peters

Siteman Cancer Center - Saint Peters

Joel Picus
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Joel Picus
Principal Investigator

Springfield

CoxHealth South Hospital

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Mercy Hospital Springfield

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Montana
Billings

Billings Clinic Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Montana Cancer Consortium CCOP

Neeraj Agarwal
Ph: 801-587-4765
Email: neeraj.agarwal@hci.utah.edu

Neeraj Agarwal
Principal Investigator

Saint Vincent Healthcare

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Bozeman

Bozeman Deaconess Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Great Falls

Benefis Healthcare- Sletten Cancer Institute

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Nebraska
Grand Island

CHI Health Saint Francis

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Omaha

Alegent Health Bergan Mercy Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Immanuel Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Lakeside Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Creighton University Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Nebraska Methodist Hospital

Ralph J. Hauke
Ph: 402-354-5144

Ralph J. Hauke
Principal Investigator

Nevada
Las Vegas

Comprehensive Cancer Centers of Nevada

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Central Valley

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Nevada Cancer Research Foundation CCOP

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Reno

Renown Regional Medical Center

Deepa Reddy Kausalya Mocherla
Ph: 775-982-4400

Deepa Reddy Kausalya Mocherla
Principal Investigator

New Hampshire
Concord

New Hampshire Oncology Hematology PA-Concord

Frederick M. Briccetti
Ph: 800-339-6484

Frederick M. Briccetti
Principal Investigator

Hooksett

New Hampshire Oncology Hematology PA-Hooksett

Frederick M. Briccetti
Ph: 800-339-6484

Frederick M. Briccetti
Principal Investigator

Laconia

LRGHealthcare-Lakes Region General Hospital

Frederick M. Briccetti
Ph: 800-339-6484

Frederick M. Briccetti
Principal Investigator

New Jersey
East Orange

Veterans Adminstration New Jersey Health Care System

Victor Tsu-Shih Chang
Ph: 800-475-2336
Email: patricia.goyer@med.va.gov

Victor Tsu-Shih Chang
Principal Investigator

New Brunswick

Rutgers Cancer Institute of New Jersey

Tina Mayer
Ph: 732-235-8675

Tina Mayer
Principal Investigator

Sparta

Sparta Cancer Treatment Center

Jean H. Hoffman-Censits
Ph: 215-955-6084

Jean H. Hoffman-Censits
Principal Investigator

New Mexico
Albuquerque

University of New Mexico

Richard C. Lauer
Ph: 505-272-6972

Richard C. Lauer
Principal Investigator

Las Cruces

Memorial Medical Center - Las Cruces

Richard C. Lauer
Ph: 505-272-6972

Richard C. Lauer
Principal Investigator

Santa Fe

Christus Saint Vincent Regional Cancer Center

Richard C. Lauer
Ph: 505-272-6972

Richard C. Lauer
Principal Investigator

New York
Buffalo

Roswell Park Cancer Institute

Ellis G. Levine
Ph: 877-275-7724

Ellis G. Levine
Principal Investigator

Veterans Affairs Western New York Health Care System-Buffalo

Lynn M. Steinbrenner
Ph: 716-862-3191

Lynn M. Steinbrenner
Principal Investigator

East Syracuse

Hematology Oncology Associates of Central New York-East Syracuse

Jeffrey J. Kirshner
Ph: 315-472-7504

Jeffrey J. Kirshner
Principal Investigator

Elmira

Arnot Ogden Medical Center/Falck Cancer Center

William Thomas Muuse
Ph: 607-271-7000

William Thomas Muuse
Principal Investigator

Glens Falls

Glens Falls Hospital

John Patrick Stoutenburg
Ph: 518-926-6700

John Patrick Stoutenburg
Principal Investigator

New York

Columbia University Medical Center

Edward Paul Gelmann
Ph: 212-305-8615

Edward Paul Gelmann
Principal Investigator

Weill Medical College of Cornell University

Scott Tadashi Tagawa
Ph: 212-746-1848

Scott Tadashi Tagawa
Principal Investigator

Rochester

University of Rochester

Jonathan Willmann Friedberg
Ph: 585-275-5830

Jonathan Willmann Friedberg
Principal Investigator

Syracuse

State University of New York Upstate Medical University

Sam Benjamin
Ph: 315-464-5476

Sam Benjamin
Principal Investigator

White Plains

Dickstein Cancer Treatment Center

Dan Costin
Ph: 914-681-2290

Dan Costin
Principal Investigator

North Carolina
Asheville

Mission Hospital-Memorial Campus

Christopher H. Chay
Ph: 828-213-4150

Christopher H. Chay
Principal Investigator

Hendersonville

Hendersonville Hematology and Oncology at Pardee

James Earl Radford
Ph: 828-696-4716

James Earl Radford
Principal Investigator

Margaret R Pardee Memorial Hospital

James Earl Radford
Ph: 828-696-4716

James Earl Radford
Principal Investigator

Park Ridge Hospital Breast Health Center

James Dewitt Bearden
Ph: 800-486-5941

James Dewitt Bearden
Principal Investigator

Kinston

Kinston Medical Specialists PA

Peter Robins Watson
Ph: 252-559-2200

Peter Robins Watson
Principal Investigator

Statesville

Iredell Memorial Hospital

Ruby Ann Grimm
Ph: 704-873-5661

Ruby Ann Grimm
Principal Investigator

North Dakota
Bismarck

Sanford Bismarck Medical Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Fargo

Roger Maris Cancer Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Clinic North-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Medical Center-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Ohio
Akron

Summa Akron City Hospital/Cooper Cancer Center

Jennifer Eileen Payne
Ph: 330-375-6101

Jennifer Eileen Payne
Principal Investigator

Barberton

Summa Barberton Hospital

Jennifer Eileen Payne
Ph: 330-375-6101

Jennifer Eileen Payne
Principal Investigator

Chillicothe

Adena Regional Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Cincinnati

The Christ Hospital

Brian A. Mannion
Ph: 513-585-2859

Brian A. Mannion
Principal Investigator

Cleveland

MetroHealth Medical Center

Bruce J. Averbook
Ph: 216-778-8526
Email: kbauchens@metrohealth.org

Bruce J. Averbook
Principal Investigator

Columbus

Grant Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Mount Carmel Health Center West

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Ohio State University Comprehensive Cancer Center

J. Paul Monk
Ph: 800-293-5066
Email: Jamesline@osumc.edu

J. Paul Monk
Principal Investigator

Riverside Methodist Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

The Mark H Zangmeister Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Dayton

Good Samaritan Hospital - Dayton

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Miami Valley Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Samaritan North Health Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Lima

Saint Rita's Medical Center

Henry Gerad
Ph: 419-226-9617

Henry Gerad
Principal Investigator

Marietta

Marietta Memorial Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Maumee

Toledo Clinic Cancer Centers-Maumee

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Portsmouth

Southern Ohio Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Springfield

Springfield Regional Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Toledo

Toledo Clinic Cancer Centers-Toledo

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Troy

Upper Valley Medical Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Westerville

Saint Ann's Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Wright-Patterson Afb

Wright-Patterson Medical Center

Roger Allen Wood
Ph: 937-257-1398

Roger Allen Wood
Principal Investigator

Oklahoma
Oklahoma City

University of Oklahoma Health Sciences Center

George B. Selby
Ph: 405-271-4272
Email: julie-traylor@ouhsc.edu

George B. Selby
Principal Investigator

Oregon
Gresham

Legacy Mount Hood Medical Center

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

Portland

Kaiser Permanente

Nagendra Ranganatha Tirumali
Ph: 503-335-2400

Nagendra Ranganatha Tirumali
Principal Investigator

Legacy Good Samaritan Hospital and Medical Center

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

Oregon Health and Science University

Julie Nicole Graff
Ph: 503-494-1080
Email: trials@ohsu.edu

Julie Nicole Graff
Principal Investigator

Tualatin

Legacy Meridian Park Hospital

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

Pennsylvania
Doylestown

Doylestown Hospital

Mitchell B. Alden
Ph: 215-345-2378
Email: lheacock@dh.org

Mitchell B. Alden
Principal Investigator

Hershey

Penn State Milton S Hershey Medical Center

Monika Joshi
Ph: 717-531-3779
Email: CTO@hmc.psu.edu

Monika Joshi
Principal Investigator

Philadelphia

Fox Chase Cancer Center

Yu-Ning Wong
Ph: 215-728-4790

Yu-Ning Wong
Principal Investigator

Thomas Jefferson University Hospital

Jean H. Hoffman-Censits
Ph: 215-955-6084

Jean H. Hoffman-Censits
Principal Investigator

Scranton

Hematology and Oncology Associates of North East Pennsylvania

Jean H. Hoffman-Censits
Ph: 215-955-6084

Jean H. Hoffman-Censits
Principal Investigator

West Reading

Reading Hospital

Terrence Paul Cescon
Ph: 610-988-9323

Terrence Paul Cescon
Principal Investigator

South Carolina
Anderson

AnMed Health Cancer Center

James Dewitt Bearden
Ph: 800-486-5941

James Dewitt Bearden
Principal Investigator

Charleston

Charleston Hematology Oncology Associates PA-St. Francis

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Charleston Hematology Oncology Associates-Roper

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Medical University of South Carolina

Michael Brian Lilly
Ph: 843-792-9321

Michael Brian Lilly
Principal Investigator

Roper Hospital

James Michael Orcutt
Ph: 843-720-8386
Email: elizabeth.strojny@roperstfrancis.com

James Michael Orcutt
Principal Investigator

Easley

Greenville Health System Cancer Institute-Easley

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Florence

McLeod Regional Medical Center

Rajesh Bajaj
Ph: 843-679-7256

Rajesh Bajaj
Principal Investigator

Greenville

Greenville Health System Cancer Institute-Butternut

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Eastside

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Faris

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Memorial Hospital

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Saint Francis Hospital

James Dewitt Bearden
Ph: 800-486-5941

James Dewitt Bearden
Principal Investigator

Greenwood

Self Regional Healthcare

Michael Brian Lilly
Ph: 843-792-9321

Michael Brian Lilly
Principal Investigator

Greer

Greenville Health System Cancer Institute-Greer

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Seneca

Greenville Health System Cancer Institute-Seneca

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Spartanburg

Greenville Health System Cancer Institute-Spartanburg

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Spartanburg Medical Center

James Dewitt Bearden
Ph: 800-486-5941

James Dewitt Bearden
Principal Investigator

South Dakota
Sioux Falls

Sanford Cancer Center-Oncology Clinic

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford USD Medical Center - Sioux Falls

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Tennessee
Chattanooga

Erlanger Medical Center

Larry Lee Schlabach
Ph: 423-778-6947

Larry Lee Schlabach
Principal Investigator

Texas
Houston

Baylor College of Medicine

Nicholas Mitsiades
Ph: 713-798-1354
Email: burton@bcm.edu

Nicholas Mitsiades
Principal Investigator

Ben Taub General Hospital

Nicholas Mitsiades
Ph: 713-798-1354
Email: burton@bcm.edu

Nicholas Mitsiades
Principal Investigator

Veterans Administration Medical Center

Nicholas Mitsiades
Ph: 713-798-1354
Email: burton@bcm.edu

Nicholas Mitsiades
Principal Investigator

Utah
Salt Lake City

Huntsman Cancer Institute/University of Utah

Neeraj Agarwal
Ph: 801-581-4477
Email: clinical.trials@hci.utah.edu

Neeraj Agarwal
Principal Investigator

Virginia
Martinsville

Memorial Hospital Of Martinsville

Sreedhar Katragadda
Ph: 276-666-7827

Sreedhar Katragadda
Principal Investigator

Washington
Bellingham

PeaceHealth Saint Joseph Medical Center

Gary E. Goodman
Ph: 206-386-2323
Email: patra.grevstad@swedish.org

Gary E. Goodman
Principal Investigator

Burien

Highline Medical Center-Main Campus

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kennewick

Kadlec Clinic Hematology and Oncology

Heather H. Cheng
Ph: 800-804-8824

Heather H. Cheng
Principal Investigator

Mount Vernon

Skagit Valley Hospital

Heather H. Cheng
Ph: 800-804-8824

Heather H. Cheng
Principal Investigator

Seattle

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Heather H. Cheng
Ph: 800-804-8824

Heather H. Cheng
Principal Investigator

Minor and James Medical PLLC

Gary E. Goodman
Ph: 206-386-2323
Email: patra.grevstad@swedish.org

Gary E. Goodman
Principal Investigator

Swedish Medical Center-First Hill

Gary E. Goodman
Ph: 206-386-2323
Email: patra.grevstad@swedish.org

Gary E. Goodman
Principal Investigator

University of Washington Medical Center

Heather H. Cheng
Ph: 800-804-8824

Heather H. Cheng
Principal Investigator

Vancouver

Legacy Salmon Creek Hospital

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

West Virginia
Charleston

West Virginia University Charleston

Steven James Jubelirer
Ph: 304-344-3457

Steven James Jubelirer
Principal Investigator

Wisconsin
Antigo

Langlade Hospital and Cancer Center

Christopher Gary Peterson
Ph: 877-405-6866

Christopher Gary Peterson
Principal Investigator

Burlington

Aurora Cancer Care-Burlington

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Chippewa Falls

Marshfield Clinic-Chippewa Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Eau Claire

Marshfield Clinic Cancer Center at Sacred Heart

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Sacred Heart Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Elkhorn

Aurora Cancer Care-Southern Lakes

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Grafton

Aurora Cancer Care-Grafton

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Green Bay

Aurora BayCare Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Green Bay Oncology at Saint Vincent Hospital

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Green Bay Oncology Limited at Saint Mary's Hospital

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Saint Mary's Hospital

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Saint Vincent Hospital

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Janesville

Mercy Health System

Emily Gray Robinson
Ph: 800-928-1103

Emily Gray Robinson
Principal Investigator

Johnson Creek

UW Cancer Center Johnson Creek

Joshua M. Lang
Ph: 877-405-6866

Joshua M. Lang
Principal Investigator

Kenosha

Aurora Cancer Care-Kenosha South

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

La Crosse

Gundersen Lutheran Medical Center

Kurt Oettel
Ph: 608-775-2385
Email: cancerctr@gundluth.org

Kurt Oettel
Principal Investigator

Ladysmith

Marshfield Clinic - Ladysmith Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Madison

University of Wisconsin Hospital and Clinics

Joshua M. Lang
Ph: 877-405-6866

Joshua M. Lang
Principal Investigator

Manitowoc

Holy Family Memorial Hospital

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Marinette

Vince Lombardi Cancer Clinic-Marinette

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Marshfield

Marshfield Clinic

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Saint Joseph's Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Menomonee Falls

Aurora Advanced Healthcare Inc-Menomonee Falls

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Milwaukee

Aurora Cancer Care-Milwaukee

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Cancer Care-Milwaukee South

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Sinai Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Froedtert and the Medical College of Wisconsin

Kathryn A. Bylow
Ph: 414-805-4380

Kathryn A. Bylow
Principal Investigator

Minocqua

Marshfield Clinic-Minocqua Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

New Richmond

Cancer Center of Western Wisconsin

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Oconto Falls

Green Bay Oncology - Oconto Falls

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Oshkosh

Vince Lombardi Cancer Clinic - Oshkosh

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Racine

Aurora Cancer Care-Racine

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Rhinelander

Marshfield Clinic at James Beck Cancer Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Saint Mary's Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Rice Lake

Marshfield Clinic-Rice Lake Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Sheboygan

Saint Nicholas Hospital

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Vince Lombardi Cancer Clinic-Sheboygan

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Stevens Point

Marshfield Clinic Cancer Care at Saint Michael's Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Saint Michael's Hospital

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Sturgeon Bay

Green Bay Oncology - Sturgeon Bay

Matthew L. Ryan
Ph: 800-432-6049

Matthew L. Ryan
Principal Investigator

Summit

Aurora Medical Center in Summit

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Two Rivers

Vince Lombardi Cancer Clinic

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Waukesha

Aurora Cancer Care-Waukesha

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Wausau

Aspirus Regional Cancer Center

Christopher Gary Peterson
Ph: 877-405-6866

Christopher Gary Peterson
Principal Investigator

Marshfield Clinic-Wausau Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Wauwatosa

Aurora Cancer Care-Milwaukee West

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

West Allis

Aurora West Allis Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Weston

Diagnostic and Treatment Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Marshfield Clinic - Weston Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Wisconsin Rapids

Marshfield Clinic - Wisconsin Rapids Center

Seth Olusegun Fagbemi
Ph: 715-389-4457

Seth Olusegun Fagbemi
Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT01809691

Note: Information about participating sites on pharmaceutical industry trials may be incomplete. Please visit the ClinicalTrials.gov record via the link above for more information about participating sites.